We’re Here to Solve What Others Have Missed

At NanoMedX, we’re on a mission to overcome the biggest obstacle in NeuroGenetics treatment: delivering therapies that actually reach the brain.

See How It WorksConnect With Our Team

Our Journey: From Vision to Breakthroughs

NanoMedX began with a bold question: Why do most therapies fail to reach the brain?

Founded by a multidisciplinary team of chemical and biomedical engineers, genetic engineers, geneticists, pharmacists, and clinical researchers, we set out to change the way neurological diseases are treated. Drawing on deep expertise in gene editing, RNA technology, nanotechnology, and drug delivery systems, we built a platform designed to overcome the greatest barrier in neurotherapeutics: direct, targeted access to the brain without invasive procedures.

Today, we're transforming that vision into real, patient-focused solutions.

Reimagining the Future of Neurological Care

Our Vision
A world where Alzheimer’s, Parkinson’s, and certain types of Autism Spectrum Disorder (ASD) are no longer life sentences.

Our Mission
To deliver precise, gene therapies that target the root causes of neurological diseases—making transformative care, safer, more accessible, and more effective for patients worldwide.

Leadership Team

Meet the leaders driving NanoMedX’s mission and growth.

Richard Boudreault
CEO

A seasoned executive guiding our corporate strategy and growth.

Dr. Eli BenDavid
Founder

A clinical researcher with deep expertise in genetics and biomedical engineering.

Ariel Cozocaru
Executive VP

Expert in driving partnerships and fostering investor relations in biotech.

Scientific Advisory Board

Meet the experts driving our innovative research.

Dr. Jacques P. Tremblay
Neuroscientific Advisor

Leading RNA-based therapeutic research at Université Laval and CHU de Québec.

Dr. Marc Lavertu
Biomedical Engineering Advisor

Director of the Biomaterial & Tissue Engineering Lab at École Polytechnique de Montréal.

Dr. Nicolas Bertrand
Pharmacology Advisor

Leading advancements in nanomedicine, pharmacology, and pharmaceutical nanoscience at Université Laval.

Dr. Avi Schroeder
Chemical Engineering and Precision Nanomedicine Advisor

Specializing in targeted drug delivery at Technion – Israel Institute of Technology.

Dr. Eli BenDavid
Medical Genetic Advisor

Physician and clinical researcher specializing in biomedical and chemical engineering, medical genetics, and venture innovation. Affiliated with CHU de Québec and the Institute of Biomedical Engineering at Polytechnique Montréal.

Open Positions